[Federal Register: May 23, 2003 (Volume 68, Number 100)]
[Page 28235]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[[Page 28235]]



Food and Drug Administration

[Docket No. 02N-0418]

Agency Information Collection Activities; Announcement of OMB 
Approval; Adverse Experience Reporting for Licensed Biological 
Products; and General Records

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Adverse Experience Reporting for 
Licensed Biological Products; and General Records'' has been approved 
by the Office of Management and Budget (OMB) under the Paperwork 
Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of January 23, 2003 
(68 FR 3262), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0308. 
The approval expires on May 31, 2005. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: May 16, 2003.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 03-12920 Filed 5-22-03; 8:45 am]